Lip Neoplasm — knowledge graph · CancerIndex

Knowledge graph · Cancer

Lip Neoplasm

subtype

Identifier: CI-CAN-00001068
Entity page: /cancer/lip-neoplasm ↗
Edges: 40

Neighbours: 14 drugs10 trials
Drawn: 24 of 24 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Lip Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived14 of 14
→ investigated in trials for	Bevacizumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lip Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Cetuximabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants	—

Lip Neoplasm studied in …STUDIED_INderived10 of 26show all (up to 200)
→ studied in	NCT04333537Phase 2/Phase 3 · recruiting Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer · condition mapped ONTOLOGY_EXACT · 26 trials mapped (5 active)	—	—	Lip Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00568490recruiting Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers · condition mapped ONTOLOGY_EXACT · 26 trials mapped (5 active)	—	—	Lip Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT02012699recruiting Integrated Cancer Repository for Cancer Research · condition mapped ALIAS · 26 trials mapped (5 active)	—	—	Malignant Lip Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT05837221recruiting Microbiome in Head and Neck Squamous Cell Carcinoma · condition mapped ALIAS · 26 trials mapped (5 active)	—	—	Malignant Lip Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT03174275Phase 2 · active not recruiting Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma · condition mapped ALIAS · 26 trials mapped (5 active)	—	—	Malignant Lip Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT03082534Phase 2 · completed Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma · condition mapped ALIAS · 26 trials mapped (5 active)	—	—	Lip Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07005115completed Serum Lipid Profile and Lip Squamous Cell Carcinoma · condition mapped ALIAS · 26 trials mapped (5 active)	—	—	Malignant Lip Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT04985357withdrawn Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs · condition mapped ALIAS · 26 trials mapped (5 active)	—	—	Lip Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05610293unknown T1 Squamous Cell Carcinomas of the Lip · condition mapped ALIAS · 26 trials mapped (5 active)	—	—	Malignant Lip Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT03602079Phase 1/Phase 2 · completed Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene · condition mapped CURATED_BROADER · 26 trials mapped (5 active)	—	—	Malignant Lip Neoplasm	1	Observed	clinicaltrials	graph →